SK Bioscience’s $1.3bn IPO comes after group signed deal to make jabs for AstraZeneca
Home/FT/South Korean Covid vaccine maker more than doubles on share debut FT South Korean Covid vaccine maker more than doubles on share debut Financial Times0 Less than a minute Facebook X LinkedIn SK Bioscience’s $1.3bn IPO comes after group signed deal to make jabs for AstraZeneca Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
